Synthetic DNA

  • April 20, 2012
Synthetic DNA

Researchers have created synthetic molecules that store and replicate genetic data.

Researchers have created the first synthetic molecules that, alongside the natural molecules DNA and RNA, are capable of storing and replicating genetic information.

Gates Cambridge alumnus Vitor Pinheiro and colleagues from Philipp Holliger’s PNAC Division at the MRC Laboratory of Molecular Biology at Cambridge used sophisticated protein engineering techniques to adapt enzymes, that in nature synthesise and replicate DNA, to establish six new genetic systems based on synthetic nucleic acids. These have the same bases as DNA but the ribose linkage between them is replaced by quite different structures.

In doing this they showed that there is no functional imperative limiting genetic information storage to RNA and DNA. Therefore, the discovery has implications for the understanding of life on Earth. As other informational molecules can be robustly synthesised and replicated, the emergence of life on Earth is likely to reflect the abundance of RNA and DNA precursors in early Earth.

One of the practical applications of the techniques developed by the team is likely to be the development of functional nucleic acids, called aptamers, with diagnostic, therapeutic and analytical applications. Aptamers can have a number of significant advantages over the current small molecule and antibody-based therapies. For example, they bind their target molecule with high specificity (like antibodies) but being smaller they are expected to have better tissue penetration. They have low-toxicity and low-immunogenicity and they can be chemically modified to improve their stability and pharmacokinetic properties.

In the past making aptamers ‘body proof’ contributed significantly to production costs. The new HNA genetic system, developed by the LMB team, addresses that issue by efficiently producing molecules that are from the outset less susceptible to enzymatic degradation and better suited for therapeutic use. The development of new aptamers could be useful in the diagnosis and treatment of cancers, haematological, ocular and inflammatory conditions, and other diseases.

The research team included collaborators from the Katholieke Universiteit Leuven in Belgium, the Center for Evolutionary Medicine and Informatics at Arizona State University and the Nucleic Acid Centre at the University of Southern Denmark. The research was funded by the Medical Research Council, the European Framework program and the European Science Foundation.

The research is published in Science today. Vitor completed his PhD in 2006 in the Biochemistry Department in Cambridge.He has been working on synthetic genetic systems at the LMB for the past couple of years.

Picture credit: dream designs and www.freedigitalphotos.net

Latest News

A leading woman in STEAM

A Gates Cambridge Scholar has been selected as one of the 75 leading women in Science, Technology, Engineering, Arts and Mathematics in India. Yama Dixit will feature in the second edition of the book She Is, published by the Red Dot Foundation in partnership with the Office of the Principal Scientific Adviser, Government of India to mark 75 […]

Tackling the obesity epidemic in Africa

When she left school, Paula-Peace James-Okoro [2022] intended to become a medical doctor, but after starting a degree in Biochemistry she discovered a passion for the subject and for using it to address one of the major health challenges facing Africa – obesity. She says: “In Africa, the rates of metabolic diseases, like obesity and […]

Triple win for Bill Gates Sr. Prize

For the first time three Gates Cambridge Scholars are sharing this year’s Bill Gates Sr. Prize in recognition of their outstanding research and social leadership. Kim van Daalen, Reetika Subramanian and Cynthia Okoye have been selected for the prize which was established by the Gates Cambridge Trustees in June 2012 in recognition of the late […]

Gates Cambridge Annual Report published

The Gates Cambridge Trust’s Annual Report 2021 is now available. It includes a summary of the Trust’s work during the year and the impact of our scholars and alumni in Cambridge and across the world. You can also read about our 20th anniversary celebrations, the many activities of our scholars and alumni, our impact in […]